Factors Associated with Persistence and Resumption of Insulin Pen Use for Patients with Type 2 Diabetes
Authors:
- 1 January 2011
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 13 (1) , 43-48
Abstract
Objective: This study assessed patient-related factors associated with persistence and resumption of using pens as insulin delivery devices. Methods: Patients (n = 549; 300 current pen users, 249 former pen users) were recruited from national panels to participate in computer-assisted telephone interviews. Measures included demographic characteristics, diabetes treatment and self-care factors, physician recommendation for pen use, perceptions of pen convenience, clinical efficacy, facilitation of self-care, cost, patient reasons for terminating pen use, and likelihood of resuming pen use among those who had terminated use. Results: Current and former pen users rated the pen higher (P < 0.05) than vial and syringe on convenience, efficacy, facilitation of self-care, and cost, except for former users' ratings of cost. Current pen users rated pens higher (P < 0.05) than former users on all these measures. In addition to more positive pen perceptions, multivariate analysis showed that current users were more likely (P < 0.05) than former users to have received a pen recommendation from their physician, have better insurance coverage, and be working. Cost was the major reason reported for terminating pen use. Self-assessed likelihood of resuming pen use was higher (P < 0.05) among those with longer duration of pen use and more positive perceptions of pen cost and convenience. Conclusions: Results suggest that physician recommendations of pen use, patient perceptions of pens, and cost and insurance coverage of pens may play an important role in persistence of pen use. Among former pen users, duration of pen use and perceptions of pens may be important factors in likelihood of patients' resuming pen use.Keywords
This publication has 25 references indexed in Scilit:
- Factors Affecting Use of Insulin Pens by Patients With Type 2 DiabetesDiabetes Care, 2008
- Health Outcomes and Economic Impact of Therapy Conversion to a Biphasic Insulin Analog Pen Among Privately Insured Patients with Type 2 Diabetes MellitusPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringeCurrent Medical Research and Opinion, 2006
- Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive TherapyAmerican Journal of Hypertension, 2006
- Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims dataClinical Therapeutics, 2006
- Quality of Life, Treatment Satisfaction, and Treatment Preference Associated With Use of a Pen Device Delivering a Premixed 70/30 Insulin Aspart Suspension (Aspart Protamine Suspension/Soluble Aspart) Versus Alternative Treatment StrategiesDiabetes Care, 2004
- Preference for insulin delivery systems among current insulin users and nonusersClinical Therapeutics, 2004
- Preference and resource utilization in elderly patients: InnoLet® versus vial/syringeDiabetes Research and Clinical Practice, 2004
- A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClinical Therapeutics, 2003
- The meaning of medications: Another look at complianceSocial Science & Medicine, 1985